Amundi Portfolio holdings
Amundi, established in 2010 through the merger of Crédit Agricole and Société Générale’s asset management arms, is Europe’s largest asset management firm, headquartered in Paris, France, overseeing €2.2 trillion ($2.3 trillion USD) in assets as of late 2024. Serving institutional clients, financial advisors, and retail investors across 35 countries, Amundi offers a broad spectrum of investment solutions, including active and passive funds, ETFs, and sustainable investing options, with a strong focus on cost efficiency and ESG (environmental, social, governance) principles. The firm’s growth has been fueled by strategic acquisitions, such as Pioneer Investments in 2017 and Lyxor in 2021, enhancing its global reach and expertise in index tracking and alternatives. Majority-owned by Crédit Agricole, Amundi combines French financial heritage with a modern, client-centric approach, maintaining a dominant position in Europe while expanding in Asia and the Americas.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$398M |
| 2 |
Apple
AAPL
|
+$326M |
| 3 |
Vertex Pharmaceuticals
VRTX
|
+$286M |
| 4 |
UnitedHealth
UNH
|
+$267M |
| 5 |
Veralto
VLTO
|
+$265M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Wells Fargo 7.5% Non Cumv Perp Conv
WFC.PRL
|
+$730M |
| 2 |
Meta Platforms (Facebook)
META
|
+$674M |
| 3 |
Costco
COST
|
+$635M |
| 4 |
Amazon
AMZN
|
+$528M |
| 5 |
Expedia Group
EXPE
|
+$491M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 29% |
| 2 | Healthcare | 13.85% |
| 3 | Consumer Discretionary | 11.46% |
| 4 | Financials | 11.04% |
| 5 | Industrials | 7.89% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
926
Woodward
WWD
$25B
| $5.71M | ﹤0.01% |
42,840
+39,372
| +1,135% | +$5.15M |
|
927
Post Holdings
POST
$4.14B
| $5.68M | ﹤0.01% |
60,586
+59,013
| +3,752% | +$5.01M |
|
|
928
Wells Fargo 7.5% Non Cumv Perp Conv
WFC.PRL
$4.68B
| $5.66M | ﹤0.01% |
4,799
-655,427
| -99% | -$730M |
|
929
Leidos
LDOS
$14.5B
| $5.63M | ﹤0.01% |
51,089
-3,942
| -7% | -$402K |
|
930
Enovix
ENVX
$923M
| $5.57M | ﹤0.01% |
515,963
-125,786
| -20% | -$1.24M |
|
931
Invesco Senior Income Trust
VVR
$456M
| $5.55M | ﹤0.01% |
1,354,239
| – | – |
|
|
EFOR
932
Everforth Inc
EFOR
$884M
| $5.5M | ﹤0.01% |
62,009
+7,905
| +15% | +$690K |
|
|
SILV
933
DELISTED
SilverCrest Metals Inc. Common Shares
SILV
| $5.49M | ﹤0.01% |
855,750
-236,153
| -22% | -$1.31M |
|
934
PVH
PVH
$3.87B
| $5.45M | ﹤0.01% |
45,073
+43,221
| +2,334% | +$3.87M |
|
935
iShares Core MSCI Pacific ETF
IPAC
$2.63B
| $5.42M | ﹤0.01% |
92,018
| – | – |
|
936
EastGroup Properties
EGP
$11.3B
| $5.41M | ﹤0.01% |
29,691
-3,532
| -11% | -$603K |
|
937
AstraZeneca
AZN
$263B
| $5.35M | ﹤0.01% |
38,848
+37,335
| +2,468% | +$4.85M |
|
|
SMAR
938
DELISTED
Smartsheet Inc.
SMAR
| $5.35M | ﹤0.01% |
114,023
-8,866
| -7% | -$378K |
|
939
Ranpak Holdings
PACK
$572M
| $5.33M | ﹤0.01% |
1,074,812
-122,904
| -10% | -$519K |
|
940
BHP
BHP
$213B
| $5.24M | ﹤0.01% |
81,096
-11,565
| -12% | -$698K |
|
941
Aramark
ARMK
$15.2B
| $5.21M | ﹤0.01% |
181,577
-257,738
| -59% | -$6.98M |
|
942
Freshpet
FRPT
$2.92B
| $5.17M | ﹤0.01% |
61,491
+58,479
| +1,942% | +$4.01M |
|
943
Grab
GRAB
$13.7B
| $5.16M | ﹤0.01% |
1,548,592
-2,235,571
| -59% | -$7.23M |
|
944
Goosehead Insurance
GSHD
$1.47B
| $5.15M | ﹤0.01% |
75,000
+45,000
| +150% | +$3.25M |
|
|
SGI
945
Somnigroup International
SGI
$15.3B
| $5.11M | ﹤0.01% |
+102,175
| New | +$4.33M |
|
946
Peloton Interactive
PTON
$2.71B
| $5.04M | ﹤0.01% |
823,354
+72,504
| +10% | +$391K |
|
947
Commercial Metals
CMC
$7.53B
| $5.01M | ﹤0.01% |
101,610
-84,275
| -45% | -$3.84M |
|
948
Teva Pharmaceuticals
TEVA
$36.2B
| $4.96M | ﹤0.01% |
434,893
-80,710
| -16% | -$754K |
|
|
WCC
949
WESCO International
WCC
$16.5B
| $4.93M | ﹤0.01% |
28,533
-79,188
| -74% | -$11.9M |
|
950
Cedar Fair
FUN
$1.8B
| $4.93M | ﹤0.01% |
130,204
-3,907
| -3% | -$147K |
|
Similar funds
Amundi's Q4 2023 Portfolio in Review
As of Q4 2023, Amundi held 2,118 positions worth $222B, up 9.2% from $203B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Amundi's Q4 2023 filing shows 107 new, 857 increased, 762 reduced and 120 closed positions. Its largest new stake was Veralto: 3,549,374 shares worth $276M. The largest sale was Wells Fargo 7.5% Non Cumv Perp Conv, an estimated $730M.
By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 28% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Amundi's largest Q4 2023 buy was Veralto: 3,549,374 shares worth $276M.
- Amundi added most to Johnson & Johnson in Q4 2023, an estimated $398M increase.
- Amundi's biggest Q4 2023 reduction was Wells Fargo 7.5% Non Cumv Perp Conv, cutting an estimated $730M.
- Amundi fully exited Activision Blizzard in Q4 2023, selling an estimated $284M.
- Amundi's ten largest holdings make up 23% of its $222B portfolio in Q4 2023.
- Amundi opened 107 new positions and closed 120 in Q4 2023.
- Amundi's portfolio value rose 9.2% quarter-over-quarter to $222B.
Based on Amundi's 13F filing for Q4 2023, filed 14 Feb 2024.